Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
78,783,577
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
10,781,064
-
Shares change
-
+1,518,971
-
Total reported value, excl. options
-
$107,630,096
-
Value change
-
+$16,345,897
-
Put/Call ratio
-
54%
-
Number of buys
-
40
-
Number of sells
-
-31
-
Price
-
$9.99
Significant Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) as of Q1 2021
94 filings reported holding CRMD - CorMedix Inc. - Common stock, $0.001 par value as of Q1 2021.
CorMedix Inc. - Common stock, $0.001 par value (CRMD) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,781,064 shares
of 78,783,577 outstanding shares and own 13.68% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,253,294 shares), VANGUARD GROUP INC (1,582,590 shares), Elliott Investment Management L.P. (1,550,523 shares), CREDIT SUISSE AG/ (753,473 shares), STATE STREET CORP (666,611 shares), GEODE CAPITAL MANAGEMENT, LLC (533,356 shares), NORTHERN TRUST CORP (335,456 shares), Cresset Asset Management, LLC (329,796 shares), MORGAN STANLEY (283,251 shares), and Nuveen Asset Management, LLC (197,224 shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.